Matthew Vincent Dolan - 04 Mar 2022 Form 3 Insider Report for DEXCOM INC (DXCM)

Role
Officer
Signature
Jereme M. Sylvain
Issuer symbol
DXCM
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
3
Filing time
10 Mar 2022, 16:39:16 UTC
Next filing
10 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DXCM Common Stock 7,546 04 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in this number are 7,501 unvested restricted stock units, 1,034 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024.

Remarks:

*SVP, Corporate Strategy/Development & New Markets